Finance

Lists
302440:KRX
SK Bioscience Co Ltd
37 000,00 KRW
+1,93%
(+700,00) 1D
19 ოქტ, 15:30:10 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 302440...
Open
36 200 KRW
High
37 175 KRW
Low
35 650 KRW
Mkt. cap
2,90 ტრლ.
Avg. vol.
66,23 ათ.
Volume
76,81 ათ.
52-wk high
61 300 KRW
52-wk low
31 800 KRW
EPS
-1 081 KRW
Shares outstanding
78,46 მლნ.
No. of employees
917
Open
36 200 KRW
High
37 175 KRW
Low
35 650 KRW
Mkt. cap
2,90 ტრლ.
Avg. vol.
66,23 ათ.
Volume
76,81 ათ.
52-wk high
61 300 KRW
52-wk low
31 800 KRW
EPS
-1 081 KRW
Shares outstanding
78,46 მლნ.
No. of employees
917
News stories
From web sources and news partners
Profile
SK Bioscience is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals. Wikipedia
About SK Bioscience Co Ltd
CEOან ჯეი-იონგ
Employees917
Founded1 ივლ. 2018
Headquarters-
Sector-
Websiteskbioscience.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
150,76 მლრ.
184,19 მლრ.
168,61 მლრ.
155,71 მლრ.
Cost of goods sold
118,04 მლრ.
179,39 მლრ.
153,75 მლრ.
114,18 მლრ.
Cost of revenue
118,04 მლრ.
179,39 მლრ.
153,75 მლრ.
114,18 მლრ.
Research and development expenses
19,88 მლრდ.
17,75 მლრდ.
20,98 მლრდ.
14,23 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,51 მლრდ.
33,59 მლრდ.
32,36 მლრდ.
37,12 მლრდ.
Operating expense
52,09 მლრდ.
56,40 მლრდ.
59,39 მლრდ.
57,26 მლრდ.
Total operating expenses
170,14 მლრ.
235,80 მლრ.
213,15 მლრ.
171,44 მლრ.
Operating income
-19,37 მლრდ.
-51,61 მლრდ.
-44,54 მლრდ.
-15,74 მლრდ.
Other non operating income
-637,92 მლნ.
-1,13 მლრდ.
-364,73 მლნ.
317,28 მლნ.
EBT including unusual items
-15,58 მლრდ.
-21,32 მლრდ.
-47,85 მლრდ.
-16,44 მლრდ.
EBT excluding unusual items
-23,07 მლრდ.
-48,65 მლრდ.
-46,46 მლრდ.
-18,45 მლრდ.
Income tax expense
-36,66 მლრდ.
35,09 მლრდ.
-11,68 მლრდ.
-2,35 მლრდ.
Effective tax rate
235,33%
-164,62%
24,42%
14,30%
Other operating expenses
281,98 მლნ.
532,04 მლნ.
261,38 მლნ.
654,37 მლნ.
Net income
24,48 მლრდ.
-57,96 მლრდ.
-33,33 მლრდ.
-17,89 მლრდ.
Net profit margin
16,24%
-31,47%
-19,77%
-11,49%
Earnings per share
313,00
-740,00
-425,00
-229,00
Interest and investment income
2,75 მლრდ.
6,81 მლრდ.
4,88 მლრდ.
3,07 მლრდ.
Interest expense
-2,67 მლრდ.
-2,04 მლრდ.
-3,73 მლრდ.
-4,24 მლრდ.
Net interest expenses
84,41 მლნ.
4,77 მლრდ.
1,15 მლრდ.
-1,17 მლრდ.
Depreciation and amortization charges
1,15 მლრდ.
1,49 მლრდ.
2,67 მლრდ.
1,89 მლრდ.
EBITDA
3,25 მლრდ.
-25,91 მლრდ.
-19,11 მლრდ.
8,72 მლრდ.
Gain or loss from assets sale
-547,83 მლნ.
-30,91 მლრდ.
105,62 მლნ.
352,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები